Skip to main content
Premium Trial:

Request an Annual Quote

Technologies on Their Last Breath?

Sage Bionetworks’ Stephen Friend lists at Xcomony five technologies that he thinks “will be relegated to museum displays in the next five (OK, maybe 10) years.” That list includes genome-wide association studies, proteomics as an “end approach” to studying disease, and “hunter-gatherer approaches” in which researchers collect clinical and genomic data from a large group, such as the Framingham cohort, to analyze themselves. Regarding GWAS, Friend writes that “single nucleotide polymorphisms (SNP) analysis isn’t going to last long as a major driver of biologic insight. Within the next one to two years, people will wake up to ‘ITEGS’— ‘It’s the entire genome, stupid.’” At In the Pipeline, Derek Lowe looks the list over. “I think the list is mostly correct,” he writes.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.